Document Classification

Section Type: RESULTS

Text: Ticagrelor was similarly more effective than clopidogrel in reducing rates of the primary endpoint in women 11. 2 vs. 13. 2 % [adjusted HR : 0. 88 (0. 74-1. 06)] and men 9. 4 vs. 11. 1 % [adjusted HR : 0. 86 (0. 76-0. 97)] (interaction P-value 0. 78), all-cause death in women 5. 8 vs. 6. 8 % [adjusted HR : 0. 90 (0. 69-1. 16)] and men 4. 0 vs. 5. 7 % [adjusted HR : 0. 80 (0. 67-0. 96)] (interaction P-value 0. 49), and definite stent thrombosis in women 1. 2 vs. 1. 4 % [adjusted HR : 0. 71 (0. 36-1. 38)] and men 1. 4 vs. 2. 1 % [adjusted HR : 0. 63 (0. 45-0. 89)] (interaction P-value 0. 78).